The revised EU Annex 1, published on 25 August 2022, contains new requirements for ensuring the container closure integrity (CCI) of sterile pharmaceutical products, causing pharmaceutical companies to reassess their CCI policies for compliance. Our experts can support you on these changing requirements in time to be prepared for the new regulations.
Watch the Lighthouse Instruments presentation to:
- Learn in detail how the new requirements of the revised EU Annex 1 may impact your strategy for ensuring CCI of sterile pharmaceutical products.
- Gain understanding of the advantages and disadvantages of CCI testing methods and why a science-based holistic approach to ensure good CCI is important.
- Gain understanding of how cold chain storage and transport can impact the CCI of sterile pharmaceutical products.